Lip-BBR was shown to reduce TNF- and IL-6 levels while increasing IL-10 and ameliorating the inflammatory state imposed on T2DM induction in rat liver tissue, as demonstrated by the current data. This evidence concerns the gene IL10 and type 2 diabetes mellitus.